Identification of Novel Mosaic Variants in Focal Epilepsy-Associated Patients’ Brain Lesions
Genes · 2025
DOI: 10.3390/genes16040421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Camila Araújo Bernardino Garcia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirao Preto 14049-900, SP, Brazil. Hauptthemen laut MEDLINE: Epilepsies, Partial, Malformations of Cortical Development, Group I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIMH NIH HHS, PRONAS.
Abstract (Originalsprache)
Focal cortical dysplasia type III (FCDIII) is a rare and complex condition associated with drug-resistant epilepsy and often characterized by cortical lamination abnormalities, along with a variety of neoplasms and vascular abnormalities.
Objectives
This study aimed to elucidate the genetic architecture underlying FCDIII through the use of whole-exome sequencing (WES) of brain and peripheral blood samples from 19 patients who had been diagnosed with FCDIII.
Methods
Variants were identified through a series of machine-learning-based detection and functional prediction methods and were not previously associated with FCDIII. Mosaic fraction scores of these variants validated the variants’ pathogenicity, and in silico and gene ontology enrichment analyses demonstrated that these variants had severe destabilizing effects on protein structure.
Results
We reported ten novel pathogenic somatic missense and loss of function variants across eight genes, including CNTNAP2, ACY1, SERAC1, and BRAF. Genetic alterations were linked to clinical manifestations, such as encephalopathies and intellectual disabilities, thereby emphasizing their role as molecular drivers of FCDIII.
Conclusions
We demonstrated that next-generation sequencing-based mosaic variant-calling pipelines are useful for the genetic diagnosis of FCDIII, opening up avenues for targeted therapies, yet further research is required to validate these findings and examine their therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirao Preto 14049-900, SP, Brazil.
- Department of Human Genetics, Utah Center for Genetic Discovery, University of Utah, Salt Lake City, UT 84112, USA.
- Department of Neuroscience, University of California, San Diego, CA 92093, USA.
- Rady Children's Institute for Genomic Medicine, San Diego, CA 92123, USA.
ORCID-Profile: Valentina Stanley, Xiaoxu Yang
Förderung
- NICHD NIH HHS
- NIMH NIH HHS
- PRONAS
- NIH/NICHD
- NIH/NIMH
Zitieren
APA
Garcia, C. A. B., Zubair, M., Santos, M. V., Lee, S. H., Graham, I. A., Stanley, V., George, R. D., Gleeson, J. G., Machado, H. R., & Yang, X. (2025). Identification of Novel Mosaic Variants in Focal Epilepsy-Associated Patients’ Brain Lesions. Genes. https://doi.org/10.3390/genes16040421
Vancouver
Garcia CAB, Zubair M, Santos MV, Lee SH, Graham IA, Stanley V, et al. Identification of Novel Mosaic Variants in Focal Epilepsy-Associated Patients’ Brain Lesions. Genes. 2025. doi:10.3390/genes16040421
BibTeX
@article{Garcia2025,
author = {Garcia, Camila Araújo Bernardino and Zubair, Muhammad and Santos, Marcelo Volpon and Lee, Sang Hyun and Graham, Ian Alfred and Stanley, Valentina and George, Renee D and Gleeson, Joseph G and Machado, Hélio Rubens and Yang, Xiaoxu},
title = {Identification of Novel Mosaic Variants in Focal Epilepsy-Associated Patients’ Brain Lesions},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16040421}
}
EUVIMED